Condition
Central Line
Total Trials
5
Recruiting
0
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
2 of 4 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed4
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06451185Not ApplicableCompletedPrimary
Statseal® for Central Venous Catheter Insertion Sites in Critical Care
NCT05415449CompletedPrimary
Exploration of Central Venous Catheter Protective Devices in the Pediatric Population: A Mixed Methods Study
NCT06708689Active Not Recruiting
Overview of Botriomycoma in Children with a Central Line: Epidemiology, Risk Factors, Treatments
NCT04211116CompletedPrimary
Central Venous Catheters in Pediatric Anesthesia and Intensive Care
NCT02314520Not ApplicableCompleted
Complications Associated With Central Venous Access in the NSICU: PICC vs CVC
Showing all 5 trials